
MANAGEMENT REPORT
8
Directors interests
The Directors have no direct interests in the ordinary shares of the Company. The Directors have interests in the
Company’s long term incentive plan, as detailed in Note 17 to the Financial Statements. James Corsellis and Mark
Brangstrup Watts are managing partners of MIM LLP which manages 75% per cent of the ordinary shares and
matching warrants, and 100% of the A shares and matching A warrants issued by the Company. James Corsellis
and Mark Brangstrup Watts are also managing partners of Marwyn Capital LLP, a firm which provides corporate
finance, company secretarial and ad-hoc managed services support to the Company. Details of the related party
transactions which occurred during the year are disclosed in Note 18 to the Financial Statements, save for the
participation in the Company’s long term incentive plan as disclosed in Note 17 to the Financial Statements.
There were no loans or guarantees granted or provided by the Company and/or any of its subsidiaries to or for
the benefit of any of the Directors.
Statement of Going Concern
The Financial Statements have been prepared on a going concern basis, which assumes that the Group will
continue to be able to meet its liabilities as they fall due for the foreseeable future. The Directors have considered
the financial position of the Group and have reviewed forecasts and budgets for a period of at least 12 months
following the approval of the Financial Statements.
At 30 June 2022, the Group has net assets of £8,247,216 (2021: £10,180,565) and a cash balance of £10,254,198
(2021: £12,255,387). The Company has sufficient resources to continue to pursue its investment strategy which
may include effecting a merger, share exchange, asset acquisition, share or debt purchase, reorganisation or
similar business combination with one or more businesses. Subject to the structure of any acquisition, the
Company may need to raise additional funds to finance the acquisition in the form of equity and/or debt. The
capital structure of the Company enables it to issue different types of shares in order to raise equity to fund an
acquisition. As set out in the Management Report, during 2022, the Company has launched the
PlacingProgramme, under which the Company has the ability to raise up to £500 million via the issuance of C
Shares. No C Shares have yet been issued as at the date of these Financial Statements. The Company can also
raise capital via the issuance of further ordinary shares or via the issuance of unlisted B shares which would be
issued in conjunction with a private placement memorandum to qualifying institutional investors, and
exchangeable into listed ordinary shares on re-admission. The ability of the Company to raise additional funds
in relation to an acquisition may affect its ability to complete that acquisition. Other factors outside of the
Company’s control may also impact on the Company’s ability to complete that acquisition. The key risks relating
to the Company’s ability to execute its stated strategy are set out on page 7.
The Company also entered into a forward purchase agreement (“FPA”) on 27 November 2020 with Marwyn
Value Investors II LP (‘’MVI II LP’’) of up to £20 million, which may be drawn for general working capital purposes
and to fund due diligence costs. Any drawdown is subject to the prior approval of MVI II LP and the satisfaction
of conditions precedent. At 30 June 2022 £12 million had been drawn down under the FPA. Whilst the FPA
provides a mechanism for the Company to raise additional funds, as any drawdown is not under the exclusive
control on the Company, all cashflow and working capital forecasts have been prepared without any further
draw down on the FPA being assumed.
Furthermore, the Directors have considered the ongoing impact of the Covid-19 pandemic, conflict in Ukraine
and current macro-economic factors on the Group’s forecast cashflows and liabilities, concluding that prior to
completing a transaction, these have no material impact on the Group due to the nature of its operations.
The Directors have also considered the ongoing operating costs expected to be incurred by the business over at
least the next 12 months. Based on their review the Directors have concluded that there are no material
uncertainties relating to going concern of the Group and as such the Financial Statements have been prepared
on a going concern basis, which assumes that the Group will continue to be able to meet its liabilities as they fall
due within the next 12 months from the date of approval of the Financial Statements.
Outlook
The Directors believe that the current market backdrop provides a compelling need for a new approach to family-
focussed financial solutions, with the opportunity to build a business through selective M&A and a strategic
vision to address this. The Company continues to progress discussions regarding potential acquisition